The Journal of antimicrobial chemotherapy · 2026
Characterization of IMI-4 carbapenemase-producing Enterobacter sp. isolated from humans and a companion animal in French Indian Ocean territories.
СтатьяПоддержка исследования: вне правительства СШАНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Wilkinson David A, Sellier Axelle, Maurines-Carboneill Cléa, Ethèves Anaïs, Rabaly Clément, Sababadichetty Loik, Belmonte Olivier, Garrigos Thomas, Diaw Cécile Squarzoni, Albrechtova Katerina, Miltgen Guillaume
Аннотация
BACKGROUND: Carbapenemase-producing Enterobacterales (CPE) are a significant public health concern, associated with high morbidity and mortality rates due to restricted antibiotic treatment options. Among the genetic determinants of CPE resistance, imipenemase (IMI) mediated resistance is an emerging problem in infections involving bacteria of the Enterobacter cloacae complex (ECC) and has been linked to worldwide clinical cases, including community-level outbreaks in the Indian Ocean region. Little is known about the potential role of animals as reservoirs of multidrug-resistant ECC bacteria.
OBJECTIVES: Characterize blaIMI-4 carbapenemase-producing ECC strains isolated from patients and a companion animal in the southwestern Indian Ocean region (Réunion and Mayotte islands).
METHODS: We used antibiotic susceptibility testing to determine available treatment and genome sequencing to characterize resistance gene variants and mobile genetic elements carrying blaIMI-4 genes.
RESULTS: blaIMI-4 ECC isolates are susceptible to new antibiotics active on Class A carbapenemase, notably β-lactams-inhibitors (ceftazidime-avibactam, meropenem-vaborbactam). The blaIMI-4 gene was identified on a common EcloIMEX-2 mobile integrative element in (i) ST 2370 Enterobacter sichuanensis isolated from a dog in Réunion and (ii) ST1845 Enterobacter roggenkampii clinical isolates from Réunion and Mayotte islands.
CONCLUSIONS: Companion animals may play a role in the persistence and spread of mobile genetic elements that confer carbapenem resistance in diverse Enterobacter species.
OBJECTIVES: Characterize blaIMI-4 carbapenemase-producing ECC strains isolated from patients and a companion animal in the southwestern Indian Ocean region (Réunion and Mayotte islands).
METHODS: We used antibiotic susceptibility testing to determine available treatment and genome sequencing to characterize resistance gene variants and mobile genetic elements carrying blaIMI-4 genes.
RESULTS: blaIMI-4 ECC isolates are susceptible to new antibiotics active on Class A carbapenemase, notably β-lactams-inhibitors (ceftazidime-avibactam, meropenem-vaborbactam). The blaIMI-4 gene was identified on a common EcloIMEX-2 mobile integrative element in (i) ST 2370 Enterobacter sichuanensis isolated from a dog in Réunion and (ii) ST1845 Enterobacter roggenkampii clinical isolates from Réunion and Mayotte islands.
CONCLUSIONS: Companion animals may play a role in the persistence and spread of mobile genetic elements that confer carbapenem resistance in diverse Enterobacter species.